A Plus Biotechnology Co (ROCO:6918) ROCE % : -2.93% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. A Plus Biotechnology Co's annualized ROCE % for the quarter that ended in Dec. 2023 was -2.93%.

A Plus Biotechnology Co ROCE % Historical Data

The historical data trend for A Plus Biotechnology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co ROCE % Chart

A Plus Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

5.78

6.46

5.42

7.06

4.89

A Plus Biotechnology Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial			0.15	5.76	8.35	12.50	-2.93

A Plus Biotechnology Co ROCE % Calculation

A Plus Biotechnology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	48.207	/	( ( (1174.513 - 173.629)	+	(1113.787 - 142.828) )	/ 2 )
	=	48.207	/	( (1000.884	+	970.959)	/ 2 )
	=	48.207	/	985.9215
	=	4.89 %

A Plus Biotechnology Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-28.89	/	( ( (1174.14 - 169.77)	+	(1113.787 - 142.828) )	/ 2 )
	=	-28.89	/	( ( 1004.37	+	970.959 )	/ 2 )
	=	-28.89	/	987.6645
	=	-2.93 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

A Plus Biotechnology Co (ROCO:6918) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

A Plus Biotechnology Co ROCE % Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

A Plus Biotechnology Co (ROCO:6918) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN

Website

https://www.aplusbio.com

A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co (ROCO:6918) Headlines

No Headlines